CHEMICAL-SYNTHETIC SERVICES in Europe

Trasis is committed to the development of cutting-edge solutions that help improve the diagnosis and treatment of major diseases among which cancers,...

Belgium Europe

CHEMICAL-SYNTHETIC SERVICES in Europe

Trasis is committed to the development of cutting-edge solutions that help improve the diagnosis and treatment of major diseases among which cancers,...

CHEMICAL-SYNTHETIC SERVICES  in Europe

About the plant

End-to-end CDMO Services

Trasis offers comprehensive services, from the chemical synthesis of small molecules and peptides to the production of ready-to-use drug solutions:

Early process development study & scaling up

  • Scalable API & precursor synthesis (from R&D to commercial production)
  • Raw material sourcing & cGMP assessment
  • Polymorph screening, impurity profiling & stability studies
  • Process analytics & regulatory (CMC) support

Industrialisation & Validation

  • Analytical standards
  • Analytical method development & validation
  • Chiral separations & compound purification
  • IND & DMF documentation support & submission
  • EU QP release support

Intermediate & API Manufacturing

  • Preclinical batch production & clinical trial supply
  • Industrial-scale API, precursor & intermediate production
  • Tech transfer & scale-up for commercialization
  • GMP & non-GMP production facilites

Formulation & Sterile Fill & Finish

  • Aseptic processing & customized formulations
  • Small molecules, peptides, macrocycles, chelators, (in)organic salts
  • Cold kits
  • Kits for bioconjugation

Certifications
  • ISO
  • EMA (EU GMP)
  • FDA (cGMP)

Activity
  • CHEMICAL-SYNTHETIC, SERVICES, Intermediates, API (Active Pharmaceutical Ingredients), Excipients, Radiopharmaceuticals manufacturing

Features
  • Uses: Investigational, Commercial (Phase IV), Preclinical, Phase I, Phase II, Phase III, Human, Veterinary
  • Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
  • DEA: N/A
  • BSL: 1, 2, 3, 4
  • Therapeutic areas: (C) Cardiovascular system, (L) Antineoplastic and immunomodulating agents, (N) Nervous system, (V09-10) Radiopharmaceuticals
  • Markets: FDA (USA), EMA (EU), TGA (Australia)

Batch Size / Reactor
  • Small, Medium, Large, 1 - 10 L, 10-100 L, 100 - 1,000 L

Services
  • Regulatory services, Manufacturing services, Analytical / QC services, Quality Assurance services, Tech transfer, Formulation mixing, Lyophilization, Research batches, Engineering batches, Scale-up, Pilot batches, Registration batches, Analytical methods development, Analytical methods validation, Release testing of raw materials, Release testing of product, Analytical methods transfer, QP in house, Batch certification / release, GMP documentation, CMC regulatory support, Salt screening, Fill and finish, Safety studies, Customized block synthesis, Impurity synthesis

Contact us

If you have any questions or suggestions, click here. We will be happy to assist you.

Want to see all the information?

Unleash the full power of MAI CDMO

Register for free

CGAM
ChemCon
VIVUNT
Cambrex
Shilpa Biologicals
Histocell